🏅 FDA Orphan Designation

ALPROLIX

Coagulation factor IX (recombinant), Fc fusion protein

Manufacturer: Bioverativ Therapeutics, Inc.

Indicated for:

Multisystem inflammatory syndrome in children and adultsOrphanHemophilia BOrphan

FDA-Approved Indications (2)

Multisystem inflammatory syndrome in children and adultsOrphan Designation

Adults and children with Hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Hemophilia BOrphan Designation

Adults and children with Hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes

Population: adults and children

Indications & Usage

Adults and children with Hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.